Gene therapy milestone looms, but field seeks better options.
Science
; 380(6647): 778-779, 2023 05 26.
Article
in En
| MEDLINE
| ID: mdl-37228210
ABSTRACT
FDA is expected to endorse Duchenne muscular dystrophy treatment, as safety concerns linger over uses of viruses.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Genetic Therapy
/
Muscular Dystrophy, Duchenne
Limits:
Humans
Language:
En
Journal:
Science
Year:
2023
Document type:
Article